AR and ovarian carcinoma: Using a cut-off of 10%, only AR showed a significant difference of expression (p=0.013) between the two studied series: the risk to develop a brain metastasis appeared 9.5 times greater in patients with AR-negative primary ovarian cancer (Table 3a).